We require your email address in order to send you alerts by email. You can unsubscribe at any time.

You can choose which alerts you receive and can unsubscribe at any time.

Unlock THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH's Credit Report?

Buy This Report

  • 12 months access to this report
  • Free email alerts for key changes
  • Includes 5 Companies House documents
  • Personal dashboard to track and monitor companies at a glance
  • Company scores, financials, risk indicators, CCJ's & payment data
  • Directors, shareholders & ownership details
Buy Now - £20.00
UNLIMITED ACCESS

Get Unlimited Reports For

£35/month

Cancel Anytime

SAVE 15%

Get Unlimited Reports For

£350/year

Cancel Anytime

Upgrade to Lite

  • 5 credit reports
  • 100 accounts downloads
  • 100 accounts exports

Your plan will start immediately and the time remaining on your existing plan will be refunded

Yes, upgrade to Lite

THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH

UK Flag 91 Boundary House, Charterhouse Street, London, London, EC1M 6HR


Lock icon Download PDF
Credit report booklet

Lock icon Unlock the Full Company Report

  • Check whether this company is legitimate
  • See if this company is likely to run into financial trouble
  • Find out who owns and runs the company
  • Avoid risky business relationships
  • Get instant updates if anything important changes
  • Access official company documents for free

THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH

Private Ltd By Guarantee w/o Share Cap

Active - Accounts Filed

13 October 1969

72190 Other research and experimental development on natural sciences and engineering - Other research and experimental development on natural sciences and engineering

Available to 08 Apr 2025. Next accounts due by 30 Jun 2026

Is THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH in debt to you?

Don't write it off. As exclusively featured on Can't Pay? We'll Take It Away!, DCBL provides a nationwide service recovering over £85 million annually.

Our unique "One Solution" works seamlessly with DCB Legal, managing debt recovery from the first letter through to High Court enforcement.

We act fast to protect your cash flow and recover what you're owed. Recover your debt with the UK's experts.

Remove These Ads

Current Directors & Secretaries

For a full in-depth analysis on each of these directors, click any of the links below

Name Role Date Of Birth Appointed
Professor Paul Emery Director
Dr Edith Margarethe Hessel Director
Dr Anthony Wood Director
Professor Paul Peter Tak Director
Mr Joseph Henry Cronly Director
Mrs Harsha Patel Director
Mrs Hazel Fiona Middleton Company Secretary
Professor Tracy Hussell Director
Professor Michael Alexander Patton Director
Mr Christopher John Coombe Director
Dr Paul Wayne Satchell Director
Mr Richard Kenneth Punt Director
Mr Mark Stefano Dighero Director
Professor Stephen Townley Holgate Director

Previous Directors & Secretaries

Remove These Ads

Mortgages and Charges

Total Outstanding

1

Total Satisfied

0

Type Created Registered Persons Entitled Status
J.p. Morgan Bank Luxembourg S.a. OUTSTANDING
Remove These Ads
Accounts
Cash £1,706,000.00 £1,420,000.00 £1,797,000.00 £3,095,000.00 £1,906,000.00
Net Worth £301,908,000.00 £271,903,000.00 £279,118,000.00 £306,428,000.00 £276,277,000.00
Total Current Liabilities £13,429,000.00 £14,109,000.00 £10,355,000.00 £9,280,000.00 £9,463,000.00
Total Current Assets £2,178,000.00 £2,788,000.00 £2,376,000.00 £3,762,000.00 £2,709,000.00
Remove These Ads

Frequently Asked Questions about THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH

Detailed answers about THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH, including incorporation, status, business activity, and accounts information.

When was THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH founded?

THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH was officially incorporated on 13 October 1969 and is registered under company number 00963832. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.

What type of company is THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH?

Private Ltd By Guarantee w/o Share Cap. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. For example, a private limited company (Ltd) limits the personal liability of its shareholders.

What is the current status of THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH?

THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.

What does THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH do?

THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH operates in the following sector: 72190 Other research and experimental development on natural sciences and engineering - Other research and experimental development on natural sciences and engineering . This provides insight into the company’s primary business activities and industry focus. Knowing the SIC code and description is useful for market research, assessing competitors, and understanding potential business risks.

What is THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH's registered address?

The registered office address of THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH is 91 Boundary House, Charterhouse Street, London, London, EC1M 6HR. This is the official address filed with Companies House for legal and statutory correspondence.

Is THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH financially stable?

Based on the latest accounts up to 08 Apr 2025, THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCH has filed financial statements showing its assets, liabilities, and overall trading performance. The next accounts are due by 30 Jun 2026. Reviewing these accounts helps assess the company’s financial stability, creditworthiness, and risk profile, which is crucial for investors, suppliers, and potential business partners.